Abigail L. Jenkins - 11 Jun 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
11 Jun 2025
Net transactions value
-$143,220
Form type
4
Filing time
12 Jun 2025, 13:59:05 UTC
Previous filing
13 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jenkins Abigail L. Director C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 12 Jun 2025 0001947032

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Non-Qualified Stock Option (right to buy) Award $143,220 -42,000 -50% $3.41 42,000 11 Jun 2025 Common Stock 42,000 $3.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date.